Instituto Nacional do Cancer

Rio de Janeiro RJ 20230 - 130

0 studies enrolling now · 2 studies all time

What they study most

Breast Neoplasms, Non-Small Cell Lung Cancer

Studies at this site

• A Study Comparing Bevacizumab Therapy With or Without Erlotinib for First-Line Treatment of Non-Small Cell Lung Cancer (ATLAS) — Completed
• Study Of CP-751,871 In Combination With Exemestane In Postmenopausal Women With Hormone Receptor Positive Advanced Breast Cancer — Stopped early